208 related articles for article (PubMed ID: 32619581)
1. Abnormal neuronal morphology and altered synaptic proteins are restored by oxytocin in autism-related SHANK3 deficient model.
Reichova A; Bacova Z; Bukatova S; Kokavcova M; Meliskova V; Frimmel K; Ostatnikova D; Bakos J
Mol Cell Endocrinol; 2020 Dec; 518():110924. PubMed ID: 32619581
[TBL] [Abstract][Full Text] [Related]
2. Expression of synaptic proteins in the hippocampus is modulated by neonatal oxytocin treatment.
Filova B; Reichova A; Zatkova M; Srancikova A; Bukatova S; Bacova Z; Bakos J
Neurosci Lett; 2020 Apr; 725():134912. PubMed ID: 32173625
[TBL] [Abstract][Full Text] [Related]
3. Shank3 Deficiency is Associated With Altered Profile of Neurotransmission Markers in Pups and Adult Mice.
Bukatova S; Renczes E; Reichova A; Filo J; Sadlonova A; Mravec B; Ostatnikova D; Bakos J; Bacova Z
Neurochem Res; 2021 Dec; 46(12):3342-3355. PubMed ID: 34453663
[TBL] [Abstract][Full Text] [Related]
4. Activation of the Oxytocin Receptor Modulates the Expression of Synaptic Adhesion Molecules in a Cell-Specific Manner.
Zatkova M; Reichova A; Bacova Z; Bakos J
J Mol Neurosci; 2019 Jun; 68(2):171-180. PubMed ID: 30888622
[TBL] [Abstract][Full Text] [Related]
5. SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region.
Mameza MG; Dvoretskova E; Bamann M; Hönck HH; Güler T; Boeckers TM; Schoen M; Verpelli C; Sala C; Barsukov I; Dityatev A; Kreienkamp HJ
J Biol Chem; 2013 Sep; 288(37):26697-708. PubMed ID: 23897824
[TBL] [Abstract][Full Text] [Related]
6. Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus.
Hassani Nia F; Woike D; Martens V; Klüssendorf M; Hönck HH; Harder S; Kreienkamp HJ
Mol Autism; 2020 Oct; 11(1):85. PubMed ID: 33115499
[TBL] [Abstract][Full Text] [Related]
7. Shank3 deficiency elicits autistic-like behaviors by activating p38α in hypothalamic AgRP neurons.
Wu S; Wang J; Zhang Z; Jin X; Xu Y; Si Y; Liang Y; Ge Y; Zhan H; Peng L; Bi W; Luo D; Li M; Meng B; Guan Q; Zhao J; Gao L; He Z
Mol Autism; 2024 Apr; 15(1):14. PubMed ID: 38570876
[TBL] [Abstract][Full Text] [Related]
8. Gene expression levels of DNA methyltransferase enzymes in
Srancikova A; Reichova A; Bacova Z; Bakos J
Endocr Regul; 2021 Dec; 55(4):234-237. PubMed ID: 34879184
[No Abstract] [Full Text] [Related]
9. Disrupted extracellular matrix and cell cycle genes in autism-associated Shank3 deficiency are targeted by lithium.
Ioannidis V; Pandey R; Bauer HF; Schön M; Bockmann J; Boeckers TM; Lutz AK
Mol Psychiatry; 2024 Mar; 29(3):704-717. PubMed ID: 38123724
[TBL] [Abstract][Full Text] [Related]
10. Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function.
Amal H; Barak B; Bhat V; Gong G; Joughin BA; Wang X; Wishnok JS; Feng G; Tannenbaum SR
Mol Psychiatry; 2020 Aug; 25(8):1835-1848. PubMed ID: 29988084
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of autism-like social deficits by targeting histone methyltransferases EHMT1/2 in Shank3-deficient mice.
Wang ZJ; Zhong P; Ma K; Seo JS; Yang F; Hu Z; Zhang F; Lin L; Wang J; Liu T; Matas E; Greengard P; Yan Z
Mol Psychiatry; 2020 Oct; 25(10):2517-2533. PubMed ID: 30659288
[TBL] [Abstract][Full Text] [Related]
12. Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators.
Duffney LJ; Zhong P; Wei J; Matas E; Cheng J; Qin L; Ma K; Dietz DM; Kajiwara Y; Buxbaum JD; Yan Z
Cell Rep; 2015 Jun; 11(9):1400-1413. PubMed ID: 26027926
[TBL] [Abstract][Full Text] [Related]
13. Increased rates of cerebral protein synthesis in Shank3 knockout mice: Implications for a link between synaptic protein deficit and dysregulated protein synthesis in autism spectrum disorder/intellectual disability.
Torossian A; Saré RM; Loutaev I; Smith CB
Neurobiol Dis; 2021 Jan; 148():105213. PubMed ID: 33276083
[TBL] [Abstract][Full Text] [Related]
14. Impaired synaptic function and hyperexcitability of the pyramidal neurons in the prefrontal cortex of autism-associated Shank3 mutant dogs.
Zhu F; Shi Q; Jiang YH; Zhang YQ; Zhao H
Mol Autism; 2024 Jan; 15(1):9. PubMed ID: 38297387
[TBL] [Abstract][Full Text] [Related]
15. Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism.
Wang W; Li C; Chen Q; van der Goes MS; Hawrot J; Yao AY; Gao X; Lu C; Zang Y; Zhang Q; Lyman K; Wang D; Guo B; Wu S; Gerfen CR; Fu Z; Feng G
J Clin Invest; 2017 May; 127(5):1978-1990. PubMed ID: 28414301
[TBL] [Abstract][Full Text] [Related]
16. Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition.
Qin L; Ma K; Wang ZJ; Hu Z; Matas E; Wei J; Yan Z
Nat Neurosci; 2018 Apr; 21(4):564-575. PubMed ID: 29531362
[TBL] [Abstract][Full Text] [Related]
17. Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function.
Jaramillo TC; Speed HE; Xuan Z; Reimers JM; Escamilla CO; Weaver TP; Liu S; Filonova I; Powell CM
Autism Res; 2017 Jan; 10(1):42-65. PubMed ID: 27492494
[TBL] [Abstract][Full Text] [Related]
18. Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4-9 Deletion Mouse Model of Autism.
Jaramillo TC; Speed HE; Xuan Z; Reimers JM; Liu S; Powell CM
Autism Res; 2016 Mar; 9(3):350-75. PubMed ID: 26559786
[TBL] [Abstract][Full Text] [Related]
19.
Schoen M; Asoglu H; Bauer HF; Müller HP; Abaei A; Sauer AK; Zhang R; Song TJ; Bockmann J; Kassubek J; Rasche V; Grabrucker AM; Boeckers TM
Front Neural Circuits; 2019; 13():6. PubMed ID: 30853900
[TBL] [Abstract][Full Text] [Related]
20. Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice.
Vyas Y; Lee K; Jung Y; Montgomery JM
Mol Brain; 2020 Aug; 13(1):110. PubMed ID: 32758248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
